rabbit polyclonal anti-sirtuin-1 Search Results


94
Bioss anti sirtuin 1 sirt 1 ab
Effects of UF extract and UDCA on the expression of angiogenic proteins in human FRO anaplastic thyroid cancer cells. The cells were treated with UF or UDCA at indicated concentrations for 48 h. The expression of angiogenic proteins TGF-β ( a ), VEGF ( b ), N-cadherin (N-Cad) ( c ), and <t>SIRT-1(d)</t> in the cells was determined by western blotting. ( A ) β-Actin was used as an internal control. The expression of each protein was calculated relative to β-actin expression. Data are representative of three independent experiments. ( B ) * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. normal cells. N, untreated cells; UF25, 25 μg/mL UF extract treatment; UF50, 50 μg/mL UF extract treatment; UDCA50, 50 μM/mL UDCA treatment; UDCA100, 100 μM/mL UDCA treatment; D, 2 nM/mL docetaxel treatment.
Anti Sirtuin 1 Sirt 1 Ab, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti sirtuin 1 sirt 1 ab/product/Bioss
Average 94 stars, based on 1 article reviews
anti sirtuin 1 sirt 1 ab - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Millipore sirtuin 1 antibody
Effects of UF extract and UDCA on the expression of angiogenic proteins in human FRO anaplastic thyroid cancer cells. The cells were treated with UF or UDCA at indicated concentrations for 48 h. The expression of angiogenic proteins TGF-β ( a ), VEGF ( b ), N-cadherin (N-Cad) ( c ), and <t>SIRT-1(d)</t> in the cells was determined by western blotting. ( A ) β-Actin was used as an internal control. The expression of each protein was calculated relative to β-actin expression. Data are representative of three independent experiments. ( B ) * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. normal cells. N, untreated cells; UF25, 25 μg/mL UF extract treatment; UF50, 50 μg/mL UF extract treatment; UDCA50, 50 μM/mL UDCA treatment; UDCA100, 100 μM/mL UDCA treatment; D, 2 nM/mL docetaxel treatment.
Sirtuin 1 Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirtuin 1 antibody/product/Millipore
Average 90 stars, based on 1 article reviews
sirtuin 1 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc mouse anti sirtuin 1 sirt1 polyclonal antibody
Effects of UF extract and UDCA on the expression of angiogenic proteins in human FRO anaplastic thyroid cancer cells. The cells were treated with UF or UDCA at indicated concentrations for 48 h. The expression of angiogenic proteins TGF-β ( a ), VEGF ( b ), N-cadherin (N-Cad) ( c ), and <t>SIRT-1(d)</t> in the cells was determined by western blotting. ( A ) β-Actin was used as an internal control. The expression of each protein was calculated relative to β-actin expression. Data are representative of three independent experiments. ( B ) * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. normal cells. N, untreated cells; UF25, 25 μg/mL UF extract treatment; UF50, 50 μg/mL UF extract treatment; UDCA50, 50 μM/mL UDCA treatment; UDCA100, 100 μM/mL UDCA treatment; D, 2 nM/mL docetaxel treatment.
Mouse Anti Sirtuin 1 Sirt1 Polyclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti sirtuin 1 sirt1 polyclonal antibody/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
mouse anti sirtuin 1 sirt1 polyclonal antibody - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
Millipore rabbit polyclonal anti-sirtuin-1
Effects of UF extract and UDCA on the expression of angiogenic proteins in human FRO anaplastic thyroid cancer cells. The cells were treated with UF or UDCA at indicated concentrations for 48 h. The expression of angiogenic proteins TGF-β ( a ), VEGF ( b ), N-cadherin (N-Cad) ( c ), and <t>SIRT-1(d)</t> in the cells was determined by western blotting. ( A ) β-Actin was used as an internal control. The expression of each protein was calculated relative to β-actin expression. Data are representative of three independent experiments. ( B ) * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. normal cells. N, untreated cells; UF25, 25 μg/mL UF extract treatment; UF50, 50 μg/mL UF extract treatment; UDCA50, 50 μM/mL UDCA treatment; UDCA100, 100 μM/mL UDCA treatment; D, 2 nM/mL docetaxel treatment.
Rabbit Polyclonal Anti Sirtuin 1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-sirtuin-1/product/Millipore
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-sirtuin-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rabbit polyclonal anti-sirtuin-1 #15404
Effects of UF extract and UDCA on the expression of angiogenic proteins in human FRO anaplastic thyroid cancer cells. The cells were treated with UF or UDCA at indicated concentrations for 48 h. The expression of angiogenic proteins TGF-β ( a ), VEGF ( b ), N-cadherin (N-Cad) ( c ), and <t>SIRT-1(d)</t> in the cells was determined by western blotting. ( A ) β-Actin was used as an internal control. The expression of each protein was calculated relative to β-actin expression. Data are representative of three independent experiments. ( B ) * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. normal cells. N, untreated cells; UF25, 25 μg/mL UF extract treatment; UF50, 50 μg/mL UF extract treatment; UDCA50, 50 μM/mL UDCA treatment; UDCA100, 100 μM/mL UDCA treatment; D, 2 nM/mL docetaxel treatment.
Rabbit Polyclonal Anti Sirtuin 1 #15404, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-sirtuin-1 #15404/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-sirtuin-1 #15404 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Proteintech rabbit anti sirtuin1
IR-61 increased Nrf2 activation and restored <t>SIRT1</t> and SIRT3 expression in cavernous tissue. (a) Representative images of SIRT1 costaining with α-SMA. Scale bar = 100 μm. (b) Representative images of SIRT3 co-staining with α-SMA and quantitative analysis of the fluorescence intensity of SIRT3. Scale bar = 100 μm ( n = 4 per group). (c) Representative images of Western blot analysis of SIRT1 and SIRT3. (d) Quantitative analysis of the SIRT1 fluorescence intensity ( n = 4 per group). (e) Relative SIRT1 and SIRT3 protein levels in the cavernous tissue ( n = 4–5 each group). (f) Western blot analysis of Nrf2 and HO-1 in the cavernous tissue. (g) Relative protein levels of Nrf2 and HO-1 in the corpus cavernosum ( n = 4 per group). * P < 0.05, the indicated group compared with the control group; ** P < 0.01, the indicated group compared with the control group; *** P < 0.001, the indicated group compared with the control group; # P < 0.05, the indicated group compared with the DM group; ## P < 0.01, the indicated group compared with the DM group; ### P < 0.001, the indicated group compared with the DM group. Nrf2: nuclear factor (erythroid-derived 2)-like 2; SIRT1: <t>sirtuin1;</t> SIRT3: sirtuin3; HO-1: heme oxygenase; α-SMA: α-smooth muscle actin; DM: diabetes mellitus; DAPI: 4',6-diamidino-2-phenylindole.
Rabbit Anti Sirtuin1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti sirtuin1/product/Proteintech
Average 96 stars, based on 1 article reviews
rabbit anti sirtuin1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc anti sirtuin 1
IR-61 increased Nrf2 activation and restored <t>SIRT1</t> and SIRT3 expression in cavernous tissue. (a) Representative images of SIRT1 costaining with α-SMA. Scale bar = 100 μm. (b) Representative images of SIRT3 co-staining with α-SMA and quantitative analysis of the fluorescence intensity of SIRT3. Scale bar = 100 μm ( n = 4 per group). (c) Representative images of Western blot analysis of SIRT1 and SIRT3. (d) Quantitative analysis of the SIRT1 fluorescence intensity ( n = 4 per group). (e) Relative SIRT1 and SIRT3 protein levels in the cavernous tissue ( n = 4–5 each group). (f) Western blot analysis of Nrf2 and HO-1 in the cavernous tissue. (g) Relative protein levels of Nrf2 and HO-1 in the corpus cavernosum ( n = 4 per group). * P < 0.05, the indicated group compared with the control group; ** P < 0.01, the indicated group compared with the control group; *** P < 0.001, the indicated group compared with the control group; # P < 0.05, the indicated group compared with the DM group; ## P < 0.01, the indicated group compared with the DM group; ### P < 0.001, the indicated group compared with the DM group. Nrf2: nuclear factor (erythroid-derived 2)-like 2; SIRT1: <t>sirtuin1;</t> SIRT3: sirtuin3; HO-1: heme oxygenase; α-SMA: α-smooth muscle actin; DM: diabetes mellitus; DAPI: 4',6-diamidino-2-phenylindole.
Anti Sirtuin 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti sirtuin 1/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
anti sirtuin 1 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Bioss cd16 polyclonal antibody
IR-61 increased Nrf2 activation and restored <t>SIRT1</t> and SIRT3 expression in cavernous tissue. (a) Representative images of SIRT1 costaining with α-SMA. Scale bar = 100 μm. (b) Representative images of SIRT3 co-staining with α-SMA and quantitative analysis of the fluorescence intensity of SIRT3. Scale bar = 100 μm ( n = 4 per group). (c) Representative images of Western blot analysis of SIRT1 and SIRT3. (d) Quantitative analysis of the SIRT1 fluorescence intensity ( n = 4 per group). (e) Relative SIRT1 and SIRT3 protein levels in the cavernous tissue ( n = 4–5 each group). (f) Western blot analysis of Nrf2 and HO-1 in the cavernous tissue. (g) Relative protein levels of Nrf2 and HO-1 in the corpus cavernosum ( n = 4 per group). * P < 0.05, the indicated group compared with the control group; ** P < 0.01, the indicated group compared with the control group; *** P < 0.001, the indicated group compared with the control group; # P < 0.05, the indicated group compared with the DM group; ## P < 0.01, the indicated group compared with the DM group; ### P < 0.001, the indicated group compared with the DM group. Nrf2: nuclear factor (erythroid-derived 2)-like 2; SIRT1: <t>sirtuin1;</t> SIRT3: sirtuin3; HO-1: heme oxygenase; α-SMA: α-smooth muscle actin; DM: diabetes mellitus; DAPI: 4',6-diamidino-2-phenylindole.
Cd16 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd16 polyclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
cd16 polyclonal antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
Bioss 8-ohdg polyclonal antibody
IR-61 increased Nrf2 activation and restored <t>SIRT1</t> and SIRT3 expression in cavernous tissue. (a) Representative images of SIRT1 costaining with α-SMA. Scale bar = 100 μm. (b) Representative images of SIRT3 co-staining with α-SMA and quantitative analysis of the fluorescence intensity of SIRT3. Scale bar = 100 μm ( n = 4 per group). (c) Representative images of Western blot analysis of SIRT1 and SIRT3. (d) Quantitative analysis of the SIRT1 fluorescence intensity ( n = 4 per group). (e) Relative SIRT1 and SIRT3 protein levels in the cavernous tissue ( n = 4–5 each group). (f) Western blot analysis of Nrf2 and HO-1 in the cavernous tissue. (g) Relative protein levels of Nrf2 and HO-1 in the corpus cavernosum ( n = 4 per group). * P < 0.05, the indicated group compared with the control group; ** P < 0.01, the indicated group compared with the control group; *** P < 0.001, the indicated group compared with the control group; # P < 0.05, the indicated group compared with the DM group; ## P < 0.01, the indicated group compared with the DM group; ### P < 0.001, the indicated group compared with the DM group. Nrf2: nuclear factor (erythroid-derived 2)-like 2; SIRT1: <t>sirtuin1;</t> SIRT3: sirtuin3; HO-1: heme oxygenase; α-SMA: α-smooth muscle actin; DM: diabetes mellitus; DAPI: 4',6-diamidino-2-phenylindole.
8 Ohdg Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/8-ohdg polyclonal antibody/product/Bioss
Average 96 stars, based on 1 article reviews
8-ohdg polyclonal antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Bioss cdc2/cdk1 polyclonal antibody
IR-61 increased Nrf2 activation and restored <t>SIRT1</t> and SIRT3 expression in cavernous tissue. (a) Representative images of SIRT1 costaining with α-SMA. Scale bar = 100 μm. (b) Representative images of SIRT3 co-staining with α-SMA and quantitative analysis of the fluorescence intensity of SIRT3. Scale bar = 100 μm ( n = 4 per group). (c) Representative images of Western blot analysis of SIRT1 and SIRT3. (d) Quantitative analysis of the SIRT1 fluorescence intensity ( n = 4 per group). (e) Relative SIRT1 and SIRT3 protein levels in the cavernous tissue ( n = 4–5 each group). (f) Western blot analysis of Nrf2 and HO-1 in the cavernous tissue. (g) Relative protein levels of Nrf2 and HO-1 in the corpus cavernosum ( n = 4 per group). * P < 0.05, the indicated group compared with the control group; ** P < 0.01, the indicated group compared with the control group; *** P < 0.001, the indicated group compared with the control group; # P < 0.05, the indicated group compared with the DM group; ## P < 0.01, the indicated group compared with the DM group; ### P < 0.001, the indicated group compared with the DM group. Nrf2: nuclear factor (erythroid-derived 2)-like 2; SIRT1: <t>sirtuin1;</t> SIRT3: sirtuin3; HO-1: heme oxygenase; α-SMA: α-smooth muscle actin; DM: diabetes mellitus; DAPI: 4',6-diamidino-2-phenylindole.
Cdc2/Cdk1 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdc2/cdk1 polyclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
cdc2/cdk1 polyclonal antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti sirtuin 1 sirt1
Progranulin deficiency led to increased <t>Sirtuin1</t> expression through peroxisome proliferators activated receptors‐γ and promoted interleukin‐10 production in efferocytes. (A) Western blot analysis of <t>SIRT1</t> in PMs. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, unpaired t test. (B) PMs were treated with DMSO or PPAR‐γ inhibitor GW9662 and assayed for SIRT1 protein after 24 h. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, *** p < .001, **** p < .0001, unpaired t test. (C) PMs were cocultured with apoptotic cells for 12 h and Il10 levels were detected by q‐PCR. The relative mRNA expression was showed as means ± SD (n = 3). ** p < .01, *** p < .001, unpaired t test. The study was repeated for three times. GW, GW9662; PM, peritoneal macrophage; PPAR‐γ, peroxisome proliferator‐activated receptor gamma; SD, standard deviation; SIRT1, sirtuin 1.
Anti Sirtuin 1 Sirt1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti sirtuin 1 sirt1/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
anti sirtuin 1 sirt1 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


Effects of UF extract and UDCA on the expression of angiogenic proteins in human FRO anaplastic thyroid cancer cells. The cells were treated with UF or UDCA at indicated concentrations for 48 h. The expression of angiogenic proteins TGF-β ( a ), VEGF ( b ), N-cadherin (N-Cad) ( c ), and SIRT-1(d) in the cells was determined by western blotting. ( A ) β-Actin was used as an internal control. The expression of each protein was calculated relative to β-actin expression. Data are representative of three independent experiments. ( B ) * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. normal cells. N, untreated cells; UF25, 25 μg/mL UF extract treatment; UF50, 50 μg/mL UF extract treatment; UDCA50, 50 μM/mL UDCA treatment; UDCA100, 100 μM/mL UDCA treatment; D, 2 nM/mL docetaxel treatment.

Journal: Molecules

Article Title: Anticancer Effects of Ursi Fel Extract and Its Active Compound, Ursodeoxycholic Acid, in FRO Anaplastic Thyroid Cancer Cells

doi: 10.3390/molecules26175309

Figure Lengend Snippet: Effects of UF extract and UDCA on the expression of angiogenic proteins in human FRO anaplastic thyroid cancer cells. The cells were treated with UF or UDCA at indicated concentrations for 48 h. The expression of angiogenic proteins TGF-β ( a ), VEGF ( b ), N-cadherin (N-Cad) ( c ), and SIRT-1(d) in the cells was determined by western blotting. ( A ) β-Actin was used as an internal control. The expression of each protein was calculated relative to β-actin expression. Data are representative of three independent experiments. ( B ) * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. normal cells. N, untreated cells; UF25, 25 μg/mL UF extract treatment; UF50, 50 μg/mL UF extract treatment; UDCA50, 50 μM/mL UDCA treatment; UDCA100, 100 μM/mL UDCA treatment; D, 2 nM/mL docetaxel treatment.

Article Snippet: Anti-vascular endothelial growth factor (VEGF) Ab (sc-146) was procured from Novus Biologicals (E. Briarwood Avenue, CO, USA), and anti-sirtuin-1 (Sirt-1) Ab (bc-0921R) was obtained from Bioss Antibodies Inc. (Woburn, MA, USA).

Techniques: Expressing, Western Blot

IR-61 increased Nrf2 activation and restored SIRT1 and SIRT3 expression in cavernous tissue. (a) Representative images of SIRT1 costaining with α-SMA. Scale bar = 100 μm. (b) Representative images of SIRT3 co-staining with α-SMA and quantitative analysis of the fluorescence intensity of SIRT3. Scale bar = 100 μm ( n = 4 per group). (c) Representative images of Western blot analysis of SIRT1 and SIRT3. (d) Quantitative analysis of the SIRT1 fluorescence intensity ( n = 4 per group). (e) Relative SIRT1 and SIRT3 protein levels in the cavernous tissue ( n = 4–5 each group). (f) Western blot analysis of Nrf2 and HO-1 in the cavernous tissue. (g) Relative protein levels of Nrf2 and HO-1 in the corpus cavernosum ( n = 4 per group). * P < 0.05, the indicated group compared with the control group; ** P < 0.01, the indicated group compared with the control group; *** P < 0.001, the indicated group compared with the control group; # P < 0.05, the indicated group compared with the DM group; ## P < 0.01, the indicated group compared with the DM group; ### P < 0.001, the indicated group compared with the DM group. Nrf2: nuclear factor (erythroid-derived 2)-like 2; SIRT1: sirtuin1; SIRT3: sirtuin3; HO-1: heme oxygenase; α-SMA: α-smooth muscle actin; DM: diabetes mellitus; DAPI: 4',6-diamidino-2-phenylindole.

Journal: Asian Journal of Andrology

Article Title: The near-infrared dye IR-61 restores erectile function in a streptozotocin-induced diabetes modelvia mitochondrial protection

doi: 10.4103/aja.aja_69_20

Figure Lengend Snippet: IR-61 increased Nrf2 activation and restored SIRT1 and SIRT3 expression in cavernous tissue. (a) Representative images of SIRT1 costaining with α-SMA. Scale bar = 100 μm. (b) Representative images of SIRT3 co-staining with α-SMA and quantitative analysis of the fluorescence intensity of SIRT3. Scale bar = 100 μm ( n = 4 per group). (c) Representative images of Western blot analysis of SIRT1 and SIRT3. (d) Quantitative analysis of the SIRT1 fluorescence intensity ( n = 4 per group). (e) Relative SIRT1 and SIRT3 protein levels in the cavernous tissue ( n = 4–5 each group). (f) Western blot analysis of Nrf2 and HO-1 in the cavernous tissue. (g) Relative protein levels of Nrf2 and HO-1 in the corpus cavernosum ( n = 4 per group). * P < 0.05, the indicated group compared with the control group; ** P < 0.01, the indicated group compared with the control group; *** P < 0.001, the indicated group compared with the control group; # P < 0.05, the indicated group compared with the DM group; ## P < 0.01, the indicated group compared with the DM group; ### P < 0.001, the indicated group compared with the DM group. Nrf2: nuclear factor (erythroid-derived 2)-like 2; SIRT1: sirtuin1; SIRT3: sirtuin3; HO-1: heme oxygenase; α-SMA: α-smooth muscle actin; DM: diabetes mellitus; DAPI: 4',6-diamidino-2-phenylindole.

Article Snippet: For immunohistochemical and immunofluorescence staining, the primary antibodies were rabbit anti-Desmin (1:200; Abcam, ab32362), goat anti-α-SMA (1:200; Abcam, ab21027), mouse anti-Calponin (1:200; Proteintech, 13938-1-AP, Rosemont, IL, USA), mouse anti-SM22α (1:100; Proteintech, 60213-1-Ig), rabbit anti-OPN (1:200; Abcam, ab8448), rabbit anti-Ras homolog gene family, member A (RhoA; 1:100; Proteintech, 10749-1-AP), rabbit anti-Rho-associated, coiled-coil containing protein kinase 1 (ROCK1; 1:100; Proteintech, 21850-1-AP), mouse anti-vimentin (1:200; Abcam, ab20346), rabbit anti-cleaved-caspase-3 (1:100; Abcam, ab13847), rabbit anti-sirtuin1 (SIRT1; 1:200; Proteintech, 13161-1-AP), rabbit anti-sirtuin3 (SIRT3; 1:200; Proteintech, 10099-1-AP), goat anti-NLRP3 (1:200; Abcam, ab4207), rabbit anti-caspase-1 (1:100; Abcam, ab179515), and mouse anti-apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC; 1:100; Santa Cruz Biotechnology, sc-514414, Santa Cruz, CA, USA).

Techniques: Activation Assay, Expressing, Staining, Fluorescence, Western Blot, Control, Derivative Assay

Progranulin deficiency led to increased Sirtuin1 expression through peroxisome proliferators activated receptors‐γ and promoted interleukin‐10 production in efferocytes. (A) Western blot analysis of SIRT1 in PMs. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, unpaired t test. (B) PMs were treated with DMSO or PPAR‐γ inhibitor GW9662 and assayed for SIRT1 protein after 24 h. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, *** p < .001, **** p < .0001, unpaired t test. (C) PMs were cocultured with apoptotic cells for 12 h and Il10 levels were detected by q‐PCR. The relative mRNA expression was showed as means ± SD (n = 3). ** p < .01, *** p < .001, unpaired t test. The study was repeated for three times. GW, GW9662; PM, peritoneal macrophage; PPAR‐γ, peroxisome proliferator‐activated receptor gamma; SD, standard deviation; SIRT1, sirtuin 1.

Journal: Immunity, Inflammation and Disease

Article Title: Progranulin deficiency suppresses allergic asthma and enhances efferocytosis via PPAR‐γ/MFG‐E8 regulation in macrophages

doi: 10.1002/iid3.779

Figure Lengend Snippet: Progranulin deficiency led to increased Sirtuin1 expression through peroxisome proliferators activated receptors‐γ and promoted interleukin‐10 production in efferocytes. (A) Western blot analysis of SIRT1 in PMs. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, unpaired t test. (B) PMs were treated with DMSO or PPAR‐γ inhibitor GW9662 and assayed for SIRT1 protein after 24 h. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, *** p < .001, **** p < .0001, unpaired t test. (C) PMs were cocultured with apoptotic cells for 12 h and Il10 levels were detected by q‐PCR. The relative mRNA expression was showed as means ± SD (n = 3). ** p < .01, *** p < .001, unpaired t test. The study was repeated for three times. GW, GW9662; PM, peritoneal macrophage; PPAR‐γ, peroxisome proliferator‐activated receptor gamma; SD, standard deviation; SIRT1, sirtuin 1.

Article Snippet: Antibodies used in our experiments were as follows: Anti‐cleaved caspase 3 (Cat. No 9664, clone 5A1E) and anti‐sirtuin 1 (SIRT1) (Cat. No. 3931 clone D60E1) were obtained from Cell Signaling Technology; anti‐MFG‐E8 (Cat. No. 377356, clone H‐3) was obtained from Santa Cruz; anti‐PPAR‐γ (Cat. No. ET1702‐57 clone JF101‐4) was obtained from HuaAn Biotechnology; anti‐PGRN (Cat. No. NBP1‐32076, polyclonal) was obtained from Novus Biologicals; anti‐GAPDH (Cat. No. 10494‐1‐AP polyclonal) was obtained from Proteintech and anti‐PE‐F4/80 Cat. No. 123109, clone BM8) was obtained from BioLegend.

Techniques: Expressing, Western Blot, Standard Deviation

Progranulin deficiency promoted the expression of milk fat globule‐epidermal growth factor 8 by upregulating peroxisome proliferators activated receptors‐γ in lung of asthmatic mice. (A) Protein levels of PPAR‐γ, MFG‐E8 and SIRT1 in mice lungs were analyzed by Western blot. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, *** p < .001, **** p < .0001, unpaired t test. (B) Protocol of establishing OVA‐induced allergic airway diseases model. (C) The total number of leukocytes in BALF. Results were shown as means ± SD. (WT PBS, n = 5, WT OVA, n = 4, PGRN KO PBS, n = 3, PGRN KO OVA, n = 4, PGRN KO OVA + GW9662, n = 4) ** p < .01, Welch's t ‐test. (D) Protein levels of MFG‐E8 in mice lungs was analyzed by Western blot. ( n = 2 or 3). The study was repeated for three times. Alum, aluminum; OVA, ovalbumin; PGRN, Progranulin; SD, standard deviation; WT, wild type.

Journal: Immunity, Inflammation and Disease

Article Title: Progranulin deficiency suppresses allergic asthma and enhances efferocytosis via PPAR‐γ/MFG‐E8 regulation in macrophages

doi: 10.1002/iid3.779

Figure Lengend Snippet: Progranulin deficiency promoted the expression of milk fat globule‐epidermal growth factor 8 by upregulating peroxisome proliferators activated receptors‐γ in lung of asthmatic mice. (A) Protein levels of PPAR‐γ, MFG‐E8 and SIRT1 in mice lungs were analyzed by Western blot. The results of densitometric analysis were showed as means ± SD ( n = 3). * p < .05, *** p < .001, **** p < .0001, unpaired t test. (B) Protocol of establishing OVA‐induced allergic airway diseases model. (C) The total number of leukocytes in BALF. Results were shown as means ± SD. (WT PBS, n = 5, WT OVA, n = 4, PGRN KO PBS, n = 3, PGRN KO OVA, n = 4, PGRN KO OVA + GW9662, n = 4) ** p < .01, Welch's t ‐test. (D) Protein levels of MFG‐E8 in mice lungs was analyzed by Western blot. ( n = 2 or 3). The study was repeated for three times. Alum, aluminum; OVA, ovalbumin; PGRN, Progranulin; SD, standard deviation; WT, wild type.

Article Snippet: Antibodies used in our experiments were as follows: Anti‐cleaved caspase 3 (Cat. No 9664, clone 5A1E) and anti‐sirtuin 1 (SIRT1) (Cat. No. 3931 clone D60E1) were obtained from Cell Signaling Technology; anti‐MFG‐E8 (Cat. No. 377356, clone H‐3) was obtained from Santa Cruz; anti‐PPAR‐γ (Cat. No. ET1702‐57 clone JF101‐4) was obtained from HuaAn Biotechnology; anti‐PGRN (Cat. No. NBP1‐32076, polyclonal) was obtained from Novus Biologicals; anti‐GAPDH (Cat. No. 10494‐1‐AP polyclonal) was obtained from Proteintech and anti‐PE‐F4/80 Cat. No. 123109, clone BM8) was obtained from BioLegend.

Techniques: Expressing, Western Blot, Standard Deviation